Table IV.
Changes in Mean Daily Drug Dosage During the 1‐y Follow‐Up in the EC (Upper Lines) and UC (Lower Lines) Groups During the 1‐y Dietary Intervention
| Baseline, Mean±SD (No.) | 6 Mo, Mean±SD (No.) | 12 Mo, Mean±SD (No.) | P Value | |
|---|---|---|---|---|
| Irbesartan, mg | ||||
| EC | 258±60 (42) | 255±60 (45) | 264±90 (49) | ns |
| UC | 273±120 (43) | 285±150 (45) | 288±150 (49) | ns |
| ns | ns | ns | ||
| Atenolol, mg | 37.5±25 (22) | 37±25 (27) | 36±25 (31) | ns |
| 43.0±20 (27) | 41±20 (29) | 48±35 (33) | ns | |
| ns | ns | ns | ||
| Lisinopril, mg | 15.6±6 (37) | 14.6±8 (36) | 15.1±6 (36) | ns |
| 15.2±6 (40) | 16.2±6 (43) | 16.6±4 (42) | ns | |
| ns | ns | ns | ||
| Chlorthalidone, mg | 14.5±5 (38) | 14.7±5 (42) | 14.2±5 (44) | ns |
| 18.2±7. (45) | 17.5±7 (47) | 18.2±7 (51) | ns | |
| 0.03 | 0.05 | 0.01 | ||
| Rosuvastatin, mg | 8.9±4 (22) | 9.3±4 (30) | 8.9±4 (35) | ns |
| 9.3±4 (38) | 10.4±6 (44) | 9.9±6 (47) | ns | |
| ns | ns | ns | ||
| Amlodipine, mg | 8.1±3 (40) | 8.1±4 (45) | 7.5±4 (41) | ns |
| 7.8±4 (35) | 8.1±4 (37) | 8.1±4 (38) | ns | |
| ns | ns | ns | ||
Abbreviations: EC, educational care; ns, not significant; SD, standard deviation; UC, usual care.